Literature DB >> 20041305

Sympathetic dysfunction of systemic right ventricle in congenitally corrected transposition of the great arteries.

Yasushi Akutsu1, Kyouichi Kaneko, Yusuke Kodama, Hui-Ling Li, Jumpei Suyama, Takehiko Gokan, Youichi Kobayashi.   

Abstract

We evaluate the systemic right ventricle (SRV) failure of congenitally corrected transposition of the great arteries using the scintigraphic studies in a case with 32-year-old male who improved the heart failure by the use of beta-adrenergic blockers. The myocardial perfusion sympathetic nervous system activity mismatch with preserved coronary flow and wall thickness indicates a distinctive feature as SRV cardiomyopathy, suggesting the importance of recovery of SRV sympathetic dysfunction for improving the prognosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20041305     DOI: 10.1007/s10554-009-9564-9

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  5 in total

1.  Comparison of cardiac sympathetic nervous function with left ventricular function and perfusion in cardiomyopathies by (123)I-MIBG SPECT and (99m)Tc-tetrofosmin electrocardiographically gated SPECT.

Authors:  C Zhao; N Shuke; W Yamamoto; A Okizaki; J Sato; Y Ishikawa; T Ohta; N Hasebe; K Kikuchi; T Aburano
Journal:  J Nucl Med       Date:  2001-07       Impact factor: 10.057

2.  Role of ischemia and infarction in late right ventricular dysfunction after atrial repair of transposition of the great arteries.

Authors:  T Millane; E J Bernard; E Jaeggi; R B Howman-Giles; R F Uren; T B Cartmill; R E Hawker; D S Celermajer
Journal:  J Am Coll Cardiol       Date:  2000-05       Impact factor: 24.094

3.  Myocardial scars determined by delayed-enhancement magnetic resonance imaging and positron emission tomography are not common in right ventricles with systemic function in long-term follow up.

Authors:  S Fratz; M Hauser; F M Bengel; A Hager; H Kaemmerer; M Schwaiger; J Hess; H C Stern
Journal:  Heart       Date:  2006-06-14       Impact factor: 5.994

4.  The case for myocardial ischemia in hypertrophic cardiomyopathy.

Authors:  Martin S Maron; Iacopo Olivotto; Barry J Maron; Sanjay K Prasad; Franco Cecchi; James E Udelson; Paolo G Camici
Journal:  J Am Coll Cardiol       Date:  2009-08-25       Impact factor: 24.094

5.  Efficacy of carvedilol treatment on cardiac function and cardiac sympathetic nerve activity in patients with dilated cardiomyopathy: comparison with metoprolol therapy.

Authors:  Takuji Toyama; Hiroshi Hoshizaki; Ryotaro Seki; Naoki Isobe; Hitoshi Adachi; Shigeto Naito; Shigeru Oshima; Koichi Taniguchi
Journal:  J Nucl Med       Date:  2003-10       Impact factor: 10.057

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.